Patents by Inventor Hongchun Qiu

Hongchun Qiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS
    Publication number: 20240041777
    Abstract: The present invention is directed to an oral pharmaceutical dosage form comprising a capsule containing at least two tablets, each tablet containing at least one different pharmaceutically active ingredient
    Type: Application
    Filed: June 15, 2023
    Publication date: February 8, 2024
    Inventors: NILS WILLIAM AHLGREN, RAGHU CAVATUR, KEVIN CHEN, MATTHEW JAMES KASER, HONGCHUN QIU
  • PHARMACEUTICAL FORMULATION
    Publication number: 20230062872
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Application
    Filed: February 9, 2022
    Publication date: March 2, 2023
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
  • Pharmaceutical formulation
    Patent number: 11278506
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: March 22, 2022
    Assignee: RB HEALTH (US) LLC
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
  • PHARMACEUTICAL FORMULATION
    Publication number: 20220079937
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin, naproxen and at least one further active which is selected to be an antitussive, a decongestant or an antihistamine.
    Type: Application
    Filed: September 27, 2021
    Publication date: March 17, 2022
    Inventors: Raghu Cavatur, Kevin Chen, Matthew James Kaser, Hongchun Qiu
  • PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS
    Publication number: 20200261373
    Abstract: The present invention is directed to an oral pharmaceutical dosage form comprising a capsule containing at least two tablets, each tablet containing at least one different pharmaceutically active ingredient
    Type: Application
    Filed: May 4, 2020
    Publication date: August 20, 2020
    Inventors: NILS WILLIAM AHLGREN, RAGHU CAVATUR, KEVIN CHEN, MATTHEW JAMES KASER, HONGCHUN QIU
  • NOVEL PHARMACEUTICAL FORMULATION
    Publication number: 20170304296
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin, naproxen and at least one further active which is selected to be an antitussive, a decongestant or an antihistamine.
    Type: Application
    Filed: October 21, 2015
    Publication date: October 26, 2017
    Inventors: RAGHU CAVATUR, KEVIN CHEN, MATTHEW JAMES KASER, HONGCHUN QIU
  • PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS
    Publication number: 20170304210
    Abstract: The present invention is directed to an oral pharmaceutical dosage form comprising a capsule containing at least two tablets, each tablet containing at least one different pharmaceutically active ingredient
    Type: Application
    Filed: October 21, 2015
    Publication date: October 26, 2017
    Inventors: NILS WILLIAM AHLGREN, RAGHU CAVATUR, KEVIN CHEN, MATTHEW JAMES KASER, HONGCHUN QIU
  • PHARMACEUTICAL FORMULATION
    Publication number: 20170100355
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Application
    Filed: October 11, 2016
    Publication date: April 13, 2017
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson